Product Indications and Use:
CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine, and associated tissues in adult and pediatric patients (including term neonates) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity.

Important Safety Information About CLARISCAN:
Contraindications
History of clinically important hypersensitivity reactions to Clariscan

May 3, 2022 — IBA (Ion Beam Applications S.A.), a leader in particle accelerator technology and the leader in dosimetry quality assurance solutions, today announces it has acquired Modus Medical Devices Inc. (Modus QA), a Canadian company based in London, Ontario, specialized in phantoms for quality assurance for

May 2, 2022 — A Scientific E-Poster presented during the 2022 ARRS Annual Meeting in New Orleans, LA illustrated how the COVID-19 pandemic disproportionately affected inhabitants of underserved communities.

May 2, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), routine visual ordinal coronary artery calcium (CAC) assessment on all chest CT examinations could identify a large number of patients who might benefit from preventive therapies.

A schematic of the 99Mo/99mTc production system based on an electron linear accelerator and activated carbon-based 99mTc generator. Image courtesy of The University of Tokyo

Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of April. This data was drawn from itnonline.com’s 132,000 viewers over the course of the month.

1. New Production Method Promises to End Medical Radioisotope Shortages

2. Comparison Chart: Ultrasound Systems
The role of radiologists in health policy and research

Reinforcing the critical role radiologists can, have and should play to remain relevant in the policy arena was the key takeaway from one particular Radiological Society of North America’s (RSNA) 2021 annual meeting in December. At “Health Policy Agenda: Are Rads at the Table?” presenters shared case studies and outcomes that emerged on a range of issues vital to radiologists and their patients — from pediatric radiology to state laws and federal research.
Many health systems are in various stages of developing digital interactions with patients that include implementing a digital front door strategy and enhanced patient portals to welcome and promote a good experience for patients when they engage care.

Many health systems are in various stages of developing digital interactions with patients that include implementing a digital front door strategy and enhanced patient portals to welcome and promote a good experience for patients when they engage care. Quickly setting up telemedicine visits during the COVID-19 pandemic accelerated one digital touch point with patients, but a comprehensive strategy around digital health incorporates much more. 
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now